Medytox, "Temporary Sales Suspension and Worst-Case Performance Expected Due to COVID-19 Virus" Stock Price 148,300 KRW (1.78%)

As of 10:32 AM on the 21st, Medytox is trading at 148,300 KRW, up 1.78% from the previous day. The trading volume is 212,471 shares, which is 69.18% of the previous day's volume. Medytox is known as a manufacturer and seller of pharmaceuticals and cosmetic pharmaceuticals.

On May 18, Minjeong Seon, a researcher at Hana Financial Investment, stated, "The decline in toxin exports due to the COVID-19 pandemic has led to a deterioration in Medytox's performance, and the resulting stock price drop is inevitable. However, the recent sharp decline caused by many uncertainties could rebound once those uncertainties are resolved. The preliminary ITC ruling is scheduled to be announced on June 5, Eastern US time. After the announcement, much of the uncertainty surrounding Medytox is expected to be alleviated." She set the target price for Medytox at 260,000 KRW.

Over the past five days, individual investors have net purchased 25,129 shares of Medytox, while foreign investors and institutions have net sold 37,713 shares and net purchased 6,800 shares, respectively.

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and financial AI specialist Thinkpool.

This content was produced with the assistance of AI translation services.